Jump to content

Neridronic acid

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 01:35, 11 July 2021 (Alter: pages. Add: s2cid, issue, year. Formatted dashes. | Use this bot. Report bugs. | Suggested by Abductive | Category:Drugs not assigned an ATC code | #UCB_Category 1173/2241). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Neridronic acid
Clinical data
ATC code
  • none
Identifiers
  • (6-Amino-1-hydroxyhexane-1,1-diyl)bis(phosphonic acid)
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.163.818 Edit this at Wikidata
Chemical and physical data
FormulaC6H17NO7P2
Molar mass277.150 g·mol−1
3D model (JSmol)
  • C(CCC(O)(P(=O)(O)O)P(=O)(O)O)CCN
  • InChI=1S/C6H17NO7P2/c7-5-3-1-2-4-6(8,15(9,10)11)16(12,13)14/h8H,1-5,7H2,(H2,9,10,11)(H2,12,13,14) ☒N
  • Key:PUUSSSIBPPTKTP-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Neridronic acid (INN; the anion is called neridronate) is a bisphosphonate. In Italy it is used to treat Osteogenesis imperfecta and Paget's disease of bone.[1]

A 2013 clinical trial suggests CRPS Type I (Complex regional pain syndrome) responds to treatment with intravenous neridronate.[2]

References

  1. ^ Gatti D, Viapiana O, Idolazzi L, Fracassi E, Adami S (2009). "Neridronic acid for the treatment of bone metabolic diseases". Expert Opin Drug Metab Toxicol. 5 (10): 1305–11. doi:10.1517/17425250903029190. PMID 19761412. S2CID 22274296.
  2. ^ Varenna M, Adami S, Rossini M, et al. (March 2013). "Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study". Rheumatology. 52 (3): 534–42. doi:10.1093/rheumatology/kes312. PMID 23204550.


Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Neridronic_acid&oldid=1033009533"